CRISPR-Pass: Gene Rescue of Nonsense Mutations Using Adenine Base Editors
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choongil Lee | - |
dc.contributor.author | Dong Hyun Jo | - |
dc.contributor.author | Gue-Ho Hwang | - |
dc.contributor.author | Jihyeon Yu | - |
dc.contributor.author | Jin Hyoung Kim | - |
dc.contributor.author | Se-eun Park | - |
dc.contributor.author | Jin Soo Kim | - |
dc.contributor.author | Jeong Hun Kim | - |
dc.contributor.author | Sangsu Bae | - |
dc.date.available | 2019-09-04T06:06:22Z | - |
dc.date.created | 2019-06-17 | - |
dc.date.issued | 2019-08 | - |
dc.identifier.issn | 1525-0016 | - |
dc.identifier.uri | https://pr.ibs.re.kr/handle/8788114/6097 | - |
dc.description.abstract | © 2019 The Author(s)A nonsense mutation is a substitutive mutation in a DNA sequence that causes a premature termination during translation and produces stalled proteins, resulting in dysfunction of a gene. Although it usually induces severe genetic disorders, there are no definite methods for inducing read through of premature termination codons (PTCs). Here, we present a targeted tool for bypassing PTCs, named CRISPR-pass, that uses CRISPR-mediated adenine base editors. CRISPR-pass, which should be applicable to 95.5% of clinically significant nonsense mutations in the ClinVar database, rescues protein synthesis in patient-derived fibroblasts, suggesting potential clinical utility. Lee et al. showed that CRISPR-pass, based on adenine base editors, would be a targeted tool for bypassing premature termination codons. This system could be applicable to ∼95% of clinically significant nonsense mutations, related to genetic diseases, in the ClinVar database | - |
dc.description.uri | 1 | - |
dc.language | 영어 | - |
dc.publisher | CELL PRESS | - |
dc.subject | base editing | - |
dc.subject | CRISPR-Cas9 | - |
dc.subject | nonsense mutation | - |
dc.subject | premature termination codon | - |
dc.subject | stop codon read through | - |
dc.title | CRISPR-Pass: Gene Rescue of Nonsense Mutations Using Adenine Base Editors | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.identifier.wosid | 000479123200005 | - |
dc.identifier.scopusid | 2-s2.0-85066306256 | - |
dc.identifier.rimsid | 68391 | - |
dc.contributor.affiliatedAuthor | Choongil Lee | - |
dc.contributor.affiliatedAuthor | Jin Soo Kim | - |
dc.identifier.doi | 10.1016/j.ymthe.2019.05.013 | - |
dc.identifier.bibliographicCitation | MOLECULAR THERAPY, v.27, no.8, pp.1364 - 1371 | - |
dc.citation.title | MOLECULAR THERAPY | - |
dc.citation.volume | 27 | - |
dc.citation.number | 8 | - |
dc.citation.startPage | 1364 | - |
dc.citation.endPage | 1371 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.subject.keywordPlus | GENOMIC DNA | - |
dc.subject.keywordPlus | CELLS | - |
dc.subject.keywordAuthor | base editing | - |
dc.subject.keywordAuthor | CRISPR-Cas9 | - |
dc.subject.keywordAuthor | nonsense mutation | - |
dc.subject.keywordAuthor | premature termination codon | - |
dc.subject.keywordAuthor | stop codon read through | - |